Before comparing them, one fact has to sit at the front: as of mid-2026, neither cagrilintide nor retatrutide is approved by the U.S
Slight variations in injection site or angle determine whether you avoid or encounter these structures
This class of drugs, called GLP-1 (glucagon-like peptide-1) agonists, are being investigated for an array of side effects, as they are used to treat diabetes and help with weight loss
Lower Incidence of GI Side Effects Due to the presence of GIP activity, many patients report less nausea and better tolerability compared to high-dose GLP-1 therapy
Compound Retatrutide Total strength 40mg Format Single pre-filled pen Brand Alluvi Batch AR1739JAT Stock In stock in the UK Documentation Janoshik report available Intended listing Laboratory research use only Documentation and handling notes Documentation Review the Alluvi product gallery, pack details, current stock status and available quality information before placing a research order
